Neuropathische Schmerzen – Pregabalin – eine Pharmakovigalenzstudie

Sanderson et al. untersuchen die Wirksamkeit von Pregabalin in der klinischen Routine.
Sanderson C et al. Pharmacovigilance in hospice / palliative care: net effect of pregabalin for neuropathic pain. BMJ Support Palliat Care 2016; 23 [Epub ahead of print]

• Literatur

• 1 Baldwin DS et al. Efficacy and safety of pregabalin in generalised anxiety disorder: A critical review of the literature. Journal of Psychopharmacology 2015; 29: 1047-60
• 2 Zhang S et al. Efficacy and safety of pregabalin for treating painful diabetic peripheral neuropathy: A meta-analysis. Acta Anaesthesiol Scand 2015; 59: 147-59
• 3 Raptis E et al. Pregabalin Vs. Opioids for the Treatment of Neuropathic Cancer Pain: A Prospective, Head-to-Head, Randomized, Open- Label Study. Pain Pract 2014; 14: 32-42
• 4 Fallon M et al. Randomized Double-Blind Trial of Pregabalin Versus Placebo in Conjunction With Palliative Radiotherapy for Cancer-Induced Bone Pain. Journal of Clinical Oncology 2016; 34: 550-6
• 5 Raptis E et al. Pregabalin Vs. Opioids for the Treatment of Neuropathic Cancer Pain: A Prospective, Head-to-Head, Randomized, Open- Label Study. Pain Pract 2014; 14: 32-42
• 6 Aboumarzouk OM et al. Pregabalin for chronic prostatitis. In: Aboumarzouk OM, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd; 1996;